| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $21.4M | +42.2% | +172.8% |
| Cost of Revenue | $18.1M | +31.9% | +39.8% |
| Gross Profit | $3.3M | +147.6% | +165.0% |
| R&D Expense | $2.5M | +16.0% | +38.1% |
| SG&A Expense | $5.5M | -8.2% | +26.9% |
| Operating Income | -$4.7M | +31.1% | +58.3% |
| Income Tax | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $73.2M | +35.1% | +108.9% |
| Accounts Receivable | $21.9M | +103.6% | +377.5% |
| Inventory | $4.7M | +7.9% | +75.6% |
| Current Assets | $106.7M | +48.5% | +137.4% |
| Total Assets | $156.5M | +27.2% | +50.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$27.6M | — | — |
| Capital Expenditures | $2.0M | — | — |
| Investing Cash Flow | -$2.0M | — | — |
| Financing Cash Flow | $48.0M | — | — |
| Free Cash Flow | -$29.7M | — | — |
| — |
| — |
| Net Income | -$3.9M | +38.9% | +64.1% |
| EPS (Basic) | -$0.03 | +40.0% | +70.0% |
| EPS (Diluted) | -$0.03 | +40.0% | +70.0% |
| $16.1M |
| +32.9% |
| +23.5% |
| Total Liabilities | $53.3M | +14.9% | +10.5% |
| Stockholders' Equity | $103.2M | +34.6% | +84.3% |